Form 4 for DGX Quest Diagnostics
Accepted 2024-05-01 00:00:00 ET · period of report 2024-04-29 · accession 0001022079-24-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | 2024-04-29 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale | $140.00 | -1,760 | 13.4K | -12% | -$246.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-29 | S | D | 1,760 | $140.00 | 13,435 | D | — | — |